Drug intelligence / Profile preview

shensu huxin decoction

Development stage: Preclinical
Lead developer: Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Shensu Huxin decoction is a traditional Chinese medicine herbal preparation, specifically a decoction, that is being investigated for its therapeutic effects. A revised version of this decoction is currently undergoing clinical trials to assess its effectiveness in improving the exercise capacity of patients with stable angina, particularly those presenting with a syndrome of qi deficiency with phlegm and blood stasis. The formulation is administered orally as granules.

Other names: Revised Shensu Huxin decoction改良的参术冠心方

Beyond the preview

Go deeper on shensu huxin decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on shensu huxin decoction.

Explore the full profile